- Announcement of Comprehensive Business Alliance(PDF)
- Launch of Distribution of GAP and GAP-screener- the Gaze Analyzing Perimeters(PDF)
- Launch of Distribution of the M22 IPL Model(PDF)
- Launch of Distribution of Medical Devices(PDF)
- Launch of a New Treatment for “Ranibizumab BS Intravitreal Injection Kit 10 mg/mL ‘Senju’”(PDF)
- Ophthalmic VEGF Inhibitor Acquisition of Marketing Approval for “Ranibizumab BS Intravitreal Injection Kit 10 mg/mL ‘Senju’”(PDF)
- Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA® Combination Ophthalmic Solution(PDF)
- Launch of Neuroptika, Inc.(PDF)
- Announcement of co-promotion of new glaucoma treatment(PDF)
- License Agreement to Development and Commercialize Azithromycin Ophthalmic Solution Using DuraSite® in Japan
- Collaboration License Agreement for the Development and Commercialization of Integrin Peptide Therapy
- To be released on May 11, 2012: “AIPHAGAN® Ophthalmic Solution 0.1%”for the treatment of Glaucoma / Ocular Hypertension (PDF)
- The approval of 『BRONUCK ®』 (bromfenac sodium hydrate ophthalmic solution)as an import drug in China(PDF)